DME (psychedelic)

DME (3,4-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-hydroxy derivative of 3,4-dimethoxyphenethylamine. DME was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.

DME
Names
Preferred IUPAC name
2-Amino-1-(3,4-dimethoxyphenyl)ethan-1-ol
Other names
3,4-Dimethoxy-beta-hydroxyphenethylamine
3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 checkY
    Key: WIUFFBGZBFVVDL-UHFFFAOYSA-N checkY
  • InChI=1/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3
    Key: WIUFFBGZBFVVDL-UHFFFAOYAL
  • COc1cc(ccc1OC)C(O)CN
  • O(c1ccc(cc1OC)C(O)CN)C
Properties
C10H15NO3
Molar mass 197.234 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References
  1. DME Entry in PiHKAL
  2. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.